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Background/aim: The management of nodules with indeterminate cytology [atypia of undetermined significance (AUS), follicular
lesion of undetermined significance (FLUS), follicular neoplasm (FN), suspicious for a follicular neoplasm (SFN), and suspicious for
malignancy (SM)] results is controversial. To assess the role of the elastography technique in the diagnosis of malignancy in the subtypes
of indeterminate thyroid nodules.
Materials and methods: We included 132 patients with indeterminate cytology who underwent thyroid surgery. Sensitivity, specificity,
area under the curve, and optimal cut-off points were calculated with receiver operating characteristic (ROC) analysis for elastography
score (ES) and strain index (SI).
Results: Malignancy was observed in 27/95 (28.4%) of the AUS-FLUS cytology and 12/24 (50%) of FN, SFN cytology. All of the 13
patients (100 %) with SM are found to be malignant on histology. In the FLUS group, nodules with ES greater or equal to 3, the presence
of malignancy was higher 17/41 (41.5%) when compared with nodules with ES smaller than 39/46 (19.6 %) (p = 0.023). In the SFN
group, 2 of 2 nodules with an ES score of 4 and 1 of 1 nodule with an ES score of 5 were malignant. In the FLUS group, 4 of 10 nodules
with an ES score of 4 and 2 of 2 nodules with an ES score of 5 were malignant.
Conclusion: Thyroid elastography may reduce unnecessary surgery for both patients with AUS/FLUS and selected SFN cytology.
Elastography appears to be helpful in follicular variants and other types of papillary thyroid cancer, however, not in follicular thyroid
cancer.
Key words: Elastography, indeterminate cytology, malignancy, thyroid

1. Introduction
Solitary thyroid nodules are seen as a common health
problem although only 4% – 6.5% of them are diagnosed
with cancer in the general population [1]. FNAB (Fine
needle aspiration biopsy) is a safe procedure to diagnose
thyroid malignancy preoperatively, practiced widely to
a high standard [2–4]. Performing ultrasound-guided
FNAB on solitary nodules has become an acceptable
method rather than the conventional one [5]. The
procedure is a useful tool even in infra-centimetric nodules
[6]. Indeterminate cytology [atypia of undetermined
significance (AUS), follicular lesion of undetermined
significance (FLUS), follicular neoplasm (FN), suspicious
for a follicular neoplasm (SFN), and suspicious for
malignancy (SM)] accounts for approximately 20% to

25% of thyroid aspirates are found to be indeterminate
results [7]. Although the aforementioned patients undergo
surgery, most of them are still found to be benign [8,9].
The prevalence of malignancy in these patients varies from
15% to 51.7% according to the presence of atypia [10].
Therefore, the indeterminate diagnostic category has been
a major challenge for both pathologists and clinicians [11].
Adjunctive methods, for example, molecular analysis
and elastography technique are used to increase diagnostic
yield [12–17]. In addition to sonographic and cytological
features, elastography may increase the sensitivity for
predicting malignancy [18,19].
Elastography is a useful method used to measure the
stiffness of thyroid nodule compared to adjacent thyroid
tissue. Malignant nodules are stiffer than benign nodules
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[15–18]. Elastography score (ES) and strain index (SI) is
seen to be higher in malignant nodules [17,20]. In a recent
study, the risk of malignancy increased approximately
2-fold for every unit increase in SR [21]. The reports
about the usefulness of elastography in patients with
indeterminate cytology are controversial [15–17,22].
The assessment of detailed cytological findings of the
above-mentioned ‘follicular-patterned thyroid lesions’ has
not been sufficient for differential diagnosis [23]. Besides
the fact that sonographic features are generally not so
helpful while differentiating between follicular adenoma
and carcinoma, elastography may be more helpful in this
subgroup.
In this study, we aimed to evaluate the diagnostic value
of elastography to predict malignancy in thyroid nodules
with indeterminate cytology. We also aimed to evaluate
whether there is any cancer risk using histopathology as
the gold standard in these subtypes or not.
2. Materials and methods
In our prospective study, we included 132 nodular goiter
patients (13 males and 119 females) with a mean age of 44 ±
11.7 years. They all underwent surgery due to indeterminate
cytology following FNAB at the Endocrinology outpatient
clinic of Ankara Dışkapı Training & Research Hospital. The
study received approval from the local ethical committee of
Ankara Dışkapı Training & Research Hospital. Following
the approval of the ethical committee, written informed
consent was obtained from each patient.
Thyroid ultrasound and elastographic examinations
were performed before FNAB using an EUB-7000HV
scanner (Hitachi Medical Corporation, Tokyo, Japan)
with a 6- to 13-MHz linear array transducer. Power
Doppler examination was also performed using the same
technology.
We evaluated the echogenicity, size, volume, margin
regularity, presence and nature of halo, calcifications, the
blood flow pattern of all nodules. Blood flow patterns were
classified as type 1 if blood flow is absent, type 2 if there
is only perinodular blood flow, type 3 if there is marked
intranodular blood flow with absent or slight perinodular
flow [24]. Itoh’s elasticity score scale was used for the
measurement of ES according to different nodule color
patterns [25].
We selected an area manually along the borderline
of the nodule then we selected a similar-sized area
beside the nodule in thyroid tissue as a reference. The
software calculated the strain index automatically. We
took the average of three consecutive measurements.
All measurements were made by three experienced
endocrinologists in this respect. The longitudinal view was
used for measurement.
FNAB was performed under ultrasound assistance
using a 25-27-gauge needle attached to a 10 mL syringe. On

average, 2–4 interventions have been made for each nodule
and all aspirates were directly smeared on glass slides
for cytomorphological examination. Then the prepared
slides were air-dried to be stained with May-GrunwaldGiemsa or alcohol fixed to be stained with Papanicolaou &
Hematoxylin-Eosin.
Following thyroidectomy, thyroid tissue was
immediately fixed in 10% buffered formalin to be processed
and embedded in paraffin to prepare 5 µ-sections to
be stained by Hematoxylin-Eosin. All cytological and
histopathological evaluations were performed by the expert
(cyto)pathologist, blinded to the elastography results.
Reporting Thyroid Cytopathology 2017 was used for the
cytological diagnoses and widely recognized guidelines
were used for the histopathological diagnoses [9].
The G-Power 3.1 software program was used to
calculate the sample size. The α level, power, and effect size
were set as 0.05, 0.95, and 0.4, respectively, which indicated
a minimum sample size of 134.
All statistical analysis was performed using SPSS
Statistics (IBM Corporation, Somers, NY) software, version
20.0. The normality of the distribution of continuous
variables was determined using the Kolmogorov–Smirnov
test. The t-test was used for normally distributed continuous
variables, and the Mann–Whitney U test was used for
those that did not fit a normal distribution. Chi-square
test or Fisher exact test were used when the variables were
categorical. Logistic regression analysis was also performed
to evaluate the relationship between the above parameters.
The sensitivity and specificity values of elastography
(score and strain index) for diagnosing malignancy
were calculated and the best cut of values for them was
calculated by receiver operating characteristic (ROC)
analysis. The area under the ROC curves for elastography
scores (ES) and strain index (SI) was calculated. Statistical
significances were considered if p values were < 0.05.
3. Results
The mean age of patients was 44 ± 11.7 years, mean TSH
was 1.96 (min 0.01-max 16) IU/mL, mean free T4 1.04
(0.55–3.72) ng/dL. The total mean thyroid volume was
20.01 ml (4.7-77.8), mean nodule volume was 5.71 (0.05–
70) mL. The mean maximum diameter of the tumor on
histopathology was 16.6 mm (0.3–55 mm). Malignancy
was observed in 27/95 (28.4%) of the patients with atypia
with undetermined significance and follicular lesion of
undetermined significance (AUS-FLUS) cytology and
12/24 (50%) of patients with follicular neoplasm (FN) and
suspicious for a follicular neoplasm (SFN) cytology. All
of the 13 patients (100 %) with suspicious of malignancy
(SM) are found to be malignant on surgical histopathology
examination (Table 1). Two of the 27 patients with the
AUS-FLUS category are reported as follicular thyroid
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Table 1. Distribution of carcinoma rate in final histopathological
diagnosis according to subtype of indeterminate FNAB cytology.
AUS-FLUS

FN-SFN

SM

Carcinoma rate 27/95 (%28.4) 12/24 (%50) 13/13 (%100)
Papillary TCA

25

7

FTC/HTC

2

5

13

Abbreviations: Atypia of unknown significance (AUS), Atypia
with undetermined significance (FLUS), Follicular neoplasia
(FN) and suspicious of follicular neoplasm cytology (SFN),
suspicious for malignancy (SM).

cancer (FTC); 25/27 of them were reported as papillary
thyroid carcinoma (PTC). 7/12 of SFN are diagnosed with
PTC. 3 of them were diagnosed with FTC, and 1 of them
was diagnosed with hurtle cell carcinoma. All nodules
with suspicious of malignancy were diagnosed with PTC.
Elastography scores and logarithmic-strain index
are found to be statistically different according to
histopathology results. In the whole group, logarithmic
SI was greater in patients with malignancy (p < 0.0001).
Similarly, the malignancy rate was higher in the patients
with ES scores greater than 4 (p = 0.001; Fischer’s exact
test). Other ultrasonographic characteristics, including
thyroid volume, nodule volume, sex, smoking, and
other parameters, did not affect final histopathology
results. Clinical, laboratory, and sonographic features
(microcalcification, nodule echogenicity, the presence
of halo, blurred margins, intranodular vascularity) that
predict malignancy were not different between subgroups
(Table 2 and 3).

In the AUS-FLUS group; the malignancy rate was 41.5%
(17/41) among the nodules with ES greater than 3 and was
19.6% (9/46) among nodules with ES score smaller than 3
(p = 0.023; Table 4). Malignancy rate was not significantly
different between nodules with ES score greater than 3 or
nodules with ES score smaller than 3 in the SFN group
(Table 4). In the SFN group, 2 nodules with an ES score
of 4 and 1 nodule with an ES score of 5 were found to be
malignant. In the FLUS group, 4 of 10 nodules with an ES
score of 4 and 2 of 2 nodules with an ES score of 5 were
found to be malignant. The specificity of elastography
scoring (greater or equal to 4) in AUS-FLUS and FN-SFN
were 90% and 100%, respectively (Table 5). Only one of the
FTC had an ES score greater than 4.
The area under the ROC curve for diagnosis of
malignancy by measuring the SI value of nodules with
FLUS cytology was 0.66 (95% confidence interval 52.9–
79.5) (Figure 1). The area under the curve of SI for SFN
and the whole group to differentiate malignant from benign
nodules were 0.813 (95 % confidence interval 0.610–1.015,
p < 0.0026) and 0.727 (95 % confidence interval 0.631-0.823,
p < 0.0001), respectively (Figure 2, 3). Table 6 shows the
best cut-off points and corresponding sensitivity, specificity
values of SIs for diagnosis of malignancy. The cut-off point
of 2.14 for SI in the FLUS group had a sensitivity of 65.2%
and specificity of 62.3 % and 2.17 for SI in the FN-SFN
group had a sensitivity of 62.5% and specificity of 90%.
4. Discussion
In this study, we found a high prevalence of cancer in patients
with AUS-FLUS (28.4%) and FN-SFN (50%) cytology
results. Currently, there is no specific tool for predicting
malignancy rate in nodules with indeterminate cytology.
Studies performed in nodules with indeterminate cytology

Table 2. Demographic, clinical, and other laboratory characteristics according to
malignancy in final histopathological diagnosis in AUS-FLUS subtype of indeterminate
FNAB cytology.
Benign

Malign

p

Age

44.27 ± 12.1

46.5 ± 11.5

*

Gender

8M/60F

2M/25F

*

TSH

2.1 (1.5–2.8)

1.8 (1.07–2.5)

*

Free T4

1.06 (0.9–1.17)

0.98 (0.92–1.03)

*

Log-anti-TPO

1.87 ± 0.8

1.5 ± 0.6

*

Log anti-Tg

1.52 ± 0.7

1.73 ± 0.6

*

Log-Total volume

1.33 ± 0.27

1.36 ± 0.27

*

Log- Nodule volume

0.33 (0.17–0.49)

0.39 (0.06–0.7)

*

Log-SI

0.28 (0.19–0.36)

0.45 (0.32–0.57)

0.023

*:p>0.05 Strain index (SI) = strain of thyroid tissue / strain of nodular lesion
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Table 3. Demographic, clinical, and other laboratory characteristics according to
malignancy in final histopathological diagnosis in FN-SFN subtype of indeterminate
FNAB cytology.
Benign

Malign

p

Age

44.27 ± 12.1

46.5 ± 11.5

*

Gender

8M/60F

2M/25F

*

TSH

2.1 (1.5–2.8)

1.8 (1.07–2.5)

*

Free T4

1.06 (0.9–1.17)

0.98 (0.92–1.03)

*

Log-anti-TPO

1.87 ± 0.8

1.5 ± 0.6

*

Log anti-Tg

1.52 ± 0.7

1.73 ± 0.6

*

Log-Total volume

1.33 ± 0.27

1.36 ± 0.27

*

Log- Nodule volume

0.33 (0.17–0.49)

0.39 (0.06–0.7)

*

Log-SI

0.28 (0.19–0.36)

0.45 (0.32–0.57)

0.023

*:p>0.05

Table 4. Distribution of elastography scores according to fine
needle aspiration cytology results and final histopathological
diagnosis.

AUS-FLUS
FN-SFN
SM

ES score

Benign

Malign

ES <3

37 (%80.4)

9 (%19.6)

ES≥3

24 (%58.5)

17 (%41.5)

ES <3

9 (%69.3)

4 (%30.7)

ES≥3

2 (%25)

6 (%75)

ES≥3

0

12 (%100)

p
0.023

Table 5. Sensitivity and specificity of elastography scoring
(greater or equal to 4) in indeterminate nodules.
Sensitivity (%)

Specificity (%)

Whole group

33.3

91.55

AUS-FLUS

23.0

90

FN-SFN

30

100

0.063

showed that suspicious features in ultrasonography guide
the decision for surgery.
Our study shows that ES score and SI measurements
are good predictors of malignancy. In contrast to previous
studies [16–18,26], clinical, laboratory, and sonographic
features (microcalcification, nodule echogenicity, the
presence of halo, blurred margins, intranodular vascularity)
that predict malignancy were not different between
subgroups of patients with indeterminate cytology.
To the best of our knowledge, our study is one of the
few studies in the literature evaluating the diagnostic value
of elastography specifically in patients with the AUS-FLUS
cytology. According to our study, elastography is a useful
diagnostic tool in patients with SFN cytology despite the
previous reports with conflicting results. Additionally,
the sensitivity of elastography scores for the diagnosis of
malignancy in patients with SFN and AUS-FLUS cytology
was low. Using an ES score greater than 4 for the diagnosis
of malignancy may increase the specificity. SI had greater
sensitivity for indeterminate nodules but not as high as

previously reported studies. We determined a cut-off value
of 2.14 for AUS-FLUS and 2.17 for SFN based on the receiver
operator characteristics (ROC) analysis to differentiate
malignancy. The sensitivity of these cut-off SI values was
similar in both groups, but specificity was higher in the SFN
group. These cut-off values were lower than the cut-offs
values reported in previously published studies [27].
In our study, ES scores in patients with follicular thyroid
carcinoma (FTC) were low. ES score of 4 was found in only
one case. Besides, follicular thyroid carcinoma generally
lacks specific features of malignancy in conventional
ultrasonography and molecular analysis may be helpful in
these patients. Generally, elastography seems to be more
helpful in follicular type papillary thyroid cancers and all
other papillary thyroid cancers. Many of the patients in
the SFN group have been diagnosed with follicular type
papillary thyroid carcinoma instead of FTC.
Although the Bethesda System for Reporting Thyroid
Cytopathology’ 2017 provides a better-defined cancer
risk in cytologically indeterminate nodules, it may not
reliably predict the malignant or benign result in final
histopathology. Since the lack of a definitive diagnosis for
these nodules, most patients with indeterminate cytology
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ROC Curve

ROC Curve
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Figure 1. Receiver operating characteristic curve (ROC) of strain
index for AUS-FLUS to distinguishing malignant from benign
nodules. The area under the curve for diagnosing malignancy
was 0.662 (95% confidence interval 52.9–79.5; p < 0.026).

undergo diagnostic surgery to establish the histopathological
diagnosis. However, only 10%–40% of surgically resected
thyroid nodules are proved to be malignant [17]. The
diagnostic operations, with their attendant expenses and
risks, could be avoided if the presurgical diagnosis of
these indeterminate nodules could reliably exclude the
malignancy.
Lobectomy may not be suitable for indeterminate
nodules in our population because many of them were
diagnosed with PTC rather than follicular tumors.
Limitations: Since the number of our SFN cases was
low for statistical evaluation, prospective studies including
more patients with SFN cytology results are needed.
The elastography technique is valuable in the diagnosis
of malignancy in a thyroid nodule with indeterminate
cytology especially if the lesion lacks the malignant features
in conventional ultrasonography. However, a low ES score
does not rule out malignancy risk in these nodules. More
powerful predictors of malignancy in these subgroups (SFN
and AUS-FLUS) of indeterminate nodules are still needed.
Conflict of interest
None of the authors has any potential conflict of interest
associated with this study.
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Figure 2. Receiver operating characteristic curve (ROC) of strain
index for FN-SFN to distinguishing malignant from benign
nodules. The area under the curve for diagnosing malignancy
was 0.813 (95 % confidence interval 0.610–1.015, p < 0.0026).
ROC Curve
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Figure 3. Receiver operating characteristic curve (ROC) of
strain index for the whole indeterminate group to distinguishing
malignant from benign nodules. The area under the curve for
diagnosing malignancy was 0.727 (95 % confidence interval
0.631–0.823, p < 0.0001).
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Table 6. Sensitivity and specificity of elastosonography index.
SI best
cut-off

Sensitivity
(%)

Specificity
(%)

AUS-FLUS

2.14

65.2

62.3

FN-SFN

2.17

62.5

90

Whole

2.48

60.5

74.6

Informed consent
The research was conducted in accordance with the
Declaration of Helsinki. The study protocol was approved
by the medical ethical commission of University of Health

Science Dışkapı Yıldırım Beyazıt Training and Research
Hospital. Informed consent was obtained from all
participants included in the study.
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